Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial

• Autor(es): Nahas, William Carlos
• Data: 2019
• Origem: Oasisbr
• Assunto(s): ANDRÓGENOS
• Tipo de Documento: Artigo científico
• Idioma: Inglês